Achieve Life Sciences Inc. (ACHV) |
|
0.5291 0.009 (1.77%)
|
02-14 16:00 |
|
Open: |
0.52 |
Pre. Close: |
0.5199 |
|
High:
|
0.545 |
Low:
|
0.5064 |
|
Volume:
|
994,934 |
Market Cap:
|
13M |
|
|
|
|
Achieve Life Sciences Inc is a specialty pharmaceutical company. The company is developing cytisine as a smoking cessation aid. The cytisine is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.551 - 0.554 |
0.554 - 0.557 |
|
Low:
|
0.502 - 0.506 |
0.506 - 0.51 |
|
Close:
|
0.524 - 0.53 |
0.53 - 0.535 |
|
Technical analysis |
as of: 2020-02-14 4:26:17 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 0.71 One year: 0.79 |
| Support: |
Support1: 0.50 Support2: 0.42 |
| Resistance: |
Resistance1: 0.61 Resistance2: 0.68 |
| Pivot: |
0.55  |
| Moving Average: |
MA(5): 0.53 MA(20): 0.57
MA(100): 0.96 MA(250): 2.04 |
| MACD: |
MACD(12,26): -0.03 Signal(9): -0.03 |
| Stochastic oscillator: |
%K(14,3): 18.77 %D(3): 15.80 |
| RSI: |
RSI(14): 41.16 |
| 52-week: |
High: 4.63 Low: 0.46 Change(%): -69.6 |
| Average Vol(K): |
3-Month: 238199 10-Days: 162155 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.ACHV has closed above bottom band by 25.1%. Bollinger Bands are 75.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to ACHV's normal range. The bands have been in this narrow range for 27 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
2020-02-06
Achieve Life Sciences Announces Agreement with the FreeMind Group to Assist in Securing Non-Dilutive Funding to Evaluate Cytisinicline in Vaping and e-Cigarette Users
SEATTLE and VANCOUVER, British Columbia, Feb. 6, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today…
2019-12-19
Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option
SEATTLE and VANCOUVER, British Columbia, Dec. 19, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today…
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ Capital Market |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
25.04 |
| Shares Float (M) |
6.91 |
|
% Held by Insiders
|
1.71 |
|
% Held by Institutions
|
28.27 |
|
Shares Short (K)
|
2020 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-2.345 |
|
Book Value (p.s.)
|
|
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-74.3 |
|
Return on Equity (ttm)
|
-151.0 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-0.670 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-15.34 |
|
Levered Free Cash Flow (M)
|
-8.98 |
Stock Valuations |
|
P/E
|
-0.23 |
|
P/E Growth Ratio
|
0.02 |
|
P/BV
|
0.53 |
|
P/S
|
|
|
P/CF
|
-0.86 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
2018-05-23 |
|
Last Split Ratio
|
0.1 |
|
7 Binary Options
|
|
Your Ad Here
|
|
